ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,265Medicare Part D Prescriptions Filled, Including Refills

Rank: 252 out of 670

$385K Total Retail Price of All Prescriptions

Rank: 282 out of 670

280 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 280 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 5,715 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
OMEPRAZOLE 370 279 1 5
LISINOPRIL 317 269 2 3
WARFARIN SODIUM 230 173 3 13
FUROSEMIDE 188 156 4 6
POTASSIUM CHLORIDE 186 159 5 16
LEVOTHYROXINE SODIUM 180 149 6 2
METOPROLOL TARTRATE 178 171 7 9
HYDROCODONE-ACETAMINOPHEN 177 146 S3 8 1
AMLODIPINE BESYLATE 162 150 9 7
METOPROLOL SUCCINATE 149 138 10 12
LOVASTATIN 138 116 11 44
LISINOPRIL-HYDROCHLOROTHIAZIDE 138 112 11 27
PRAVASTATIN SODIUM 137 109 13 19
GABAPENTIN 131 70 14 11
SERTRALINE HCL 130 93 15 22
FLUTICASONE PROPIONATE 122 107 16 37
METFORMIN HCL 120 96 17 8
SIMVASTATIN 107 98 18 4
HYDROCHLOROTHIAZIDE 103 98 19 10
ATENOLOL 92 62 20 17
LOSARTAN POTASSIUM 89 79 21 26
CRESTOR 82 35 22 18
LOSARTAN-HYDROCHLOROTHIAZIDE 82 57 22 73
ATORVASTATIN CALCIUM 81 76 24 15
GLIPIZIDE 80 58 25 67
TAMSULOSIN HCL 79 67 26 30
NIFEDIPINE ER 75 72 27 145
PAROXETINE HCL 74 43 28 52
TRAMADOL HCL 74 32 28 21
CITALOPRAM HBR 74 48 28 20
TRAZODONE HCL 70 68 31 39
DONEPEZIL HCL 64 64 32 31
ALENDRONATE SODIUM 64 62 32 43
ADVAIR DISKUS 62 46 34 42
KLOR-CON 10 60 50 35 166
NEXIUM 59 28 36 14
MIRTAZAPINE 57 57 37 59
GLIPIZIDE ER 50 50 38 127
ZOLPIDEM TARTRATE 50 20 38 23
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 5, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.